Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000378405 | SCV000468083 | uncertain significance | Primary ciliary dyskinesia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000378405 | SCV002614479 | uncertain significance | Primary ciliary dyskinesia | 2022-02-17 | criteria provided, single submitter | clinical testing | The p.D1141V variant (also known as c.3422A>T), located in coding exon 17 of the DNAH11 gene, results from an A to T substitution at nucleotide position 3422. The aspartic acid at codon 1141 is replaced by valine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV000378405 | SCV003445028 | benign | Primary ciliary dyskinesia | 2023-10-15 | criteria provided, single submitter | clinical testing |